The increase in both DNAM-1+ and KLRG1+ NK cells in Cish-deficient mice suggests that under steady state conditions, CIS plays a role in regulating the IL-15-dependent differentiation of NK cells in vivo. The gene discussed is IL15; the disease is in situ carcinoma.